Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Cohen

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Studies in Health Technology and Informatics|April 2, 2013
Studies in Health Technology and Informatics. Biophotonics in pathology. PrefaceStanley Cohen
Current Rheumatology Reports|July 24, 2020
JAK Inhibitors: What Is New?Virginia Reddy, Stanley Cohen
Current Opinion in Rheumatology|February 19, 2010
Kinase inhibitors: a new approach to rheumatoid arthritis treatmentStanley Cohen, Roy Fleischmann
Cureus|March 20, 2025
A Severe Case of Nuclear Matrix Protein-2-Positive Dermatomyositis With Negative Malignancy WorkupShreya Kondle, Stanley Cohen
Gastroenterology|September 13, 2008
Searching for new clues in inflammatory bowel disease: tell tales from pediatric IBD natural history studiesSubra Kugathasan, Stanley Cohen
Current Opinion in Rheumatology|September 8, 2023
Janus kinase inhibitors: efficacy and safetyStanley Cohen, Virginia Reddy
Current Opinion in Rheumatology|March 26, 2021
Role of Janus Kinase inhibitors in rheumatoid arthritis treatmentVirginia Reddy, Stanley Cohen
Annals of the Rheumatic Diseases|August 12, 2010
The American College of Rheumatology/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changerStanley Cohen, Paul Emery
Current Opinion in Rheumatology|March 18, 2017
Biosimilars: implications for rheumatoid arthritis therapyStanley Cohen, Jonathan Kay
Arthritis and Rheumatism|September 28, 2010
The American College of Rheumatology/European League Against Rheumatism criteria for the classification of rheumatoid arthritis: a game changerStanley Cohen, Paul Emery
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Studies in Health Technology and Informatics|April 2, 2013
Studies in Health Technology and Informatics. Biophotonics in pathology. PrefaceStanley Cohen
Current Rheumatology Reports|July 24, 2020
JAK Inhibitors: What Is New?Virginia Reddy, Stanley Cohen
Current Opinion in Rheumatology|February 19, 2010
Kinase inhibitors: a new approach to rheumatoid arthritis treatmentStanley Cohen, Roy Fleischmann
Cureus|March 20, 2025
A Severe Case of Nuclear Matrix Protein-2-Positive Dermatomyositis With Negative Malignancy WorkupShreya Kondle, Stanley Cohen
Gastroenterology|September 13, 2008
Searching for new clues in inflammatory bowel disease: tell tales from pediatric IBD natural history studiesSubra Kugathasan, Stanley Cohen
Current Opinion in Rheumatology|September 8, 2023
Janus kinase inhibitors: efficacy and safetyStanley Cohen, Virginia Reddy
Current Opinion in Rheumatology|March 26, 2021
Role of Janus Kinase inhibitors in rheumatoid arthritis treatmentVirginia Reddy, Stanley Cohen
Annals of the Rheumatic Diseases|August 12, 2010
The American College of Rheumatology/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changerStanley Cohen, Paul Emery
Current Opinion in Rheumatology|March 18, 2017
Biosimilars: implications for rheumatoid arthritis therapyStanley Cohen, Jonathan Kay
Arthritis and Rheumatism|September 28, 2010
The American College of Rheumatology/European League Against Rheumatism criteria for the classification of rheumatoid arthritis: a game changerStanley Cohen, Paul Emery
Pageof 12